$LFT
Lument Finance Trust, Inc. Stock $lft

$lft Overview Financials Valuation SEC Filings Company Website

2020 Q2 Form 10-Q Financial Statement

#000162828020012181 Filed on August 07, 2020

Income Statement

Concept	2020 Q2	2019 Q2
Revenue	$8.480M	$10.29M
YoY Change	-17.58%	-41.38%
Cost Of Revenue	$3.700M	$6.240M
YoY Change	-40.71%	-51.93%
Gross Profit	$4.780M	$4.050M
YoY Change	18.02%	-115.62%
Gross Profit Margin	56.37%	39.36%
Selling, General & Admin	$1.970M	$2.030M
YoY Change	-2.96%	-7.31%
% of Gross Profit	41.21%	50.12%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$2.803M	$2.176M
YoY Change	28.81%	-8.95%
Operating Profit	$1.977M	$1.874M
YoY Change	5.5%	-106.62%
Interest Expense	$3.696M	$6.242M
YoY Change	-40.79%	-51.91%
% of Operating Profit	186.95%	333.08%
Other Income/Expense, Net	-$171.0K	-$274.0K
YoY Change	-37.59%	-98.84%
Pretax Income	$1.810M	$1.600M
YoY Change	13.13%	-107.45%
Income Tax	-$68.27K	$203.0K
% Of Pretax Income	-3.77%	12.69%
Net Earnings	$1.879M	$1.394M
YoY Change	34.77%	-106.49%
Net Earnings / Revenue	22.15%	13.55%
Basic Earnings Per Share
Diluted Earnings Per Share	$75.38K	$58.67K
COMMON SHARES
Basic Shares Outstanding	24.94M shares	23.68M shares
Diluted Shares Outstanding	24.94M shares	23.69M shares

Balance Sheet

Concept	2020 Q2	2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.900M	$7.200M
YoY Change	23.61%	-90.19%
Cash & Equivalents	$8.857M	$7.164M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$34.90M	$9.800M
YoY Change	256.12%	-89.77%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$7.400M	$43.00M
YoY Change	-82.79%	430.86%
Total Long-Term Assets	$620.8M	$647.6M
YoY Change	-4.14%	78.03%
TOTAL ASSETS
Total Short-Term Assets	$34.90M	$9.800M
Total Long-Term Assets	$620.8M	$647.6M
Total Assets	$655.7M	$657.4M
YoY Change	-0.26%	43.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$600.0K	$400.0K
YoY Change	50.0%	100.0%
Accrued Expenses	$400.0K	$900.0K
YoY Change	-55.56%	80.0%
Deferred Revenue
YoY Change
Short-Term Debt	$498.3M	$504.9M
YoY Change	-1.31%	75.5%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$502.1M	$509.2M
YoY Change	-1.39%	75.83%
LONG-TERM LIABILITIES
Long-Term Debt	$39.50M	$39.20M
YoY Change	0.77%	101.03%
Other Long-Term Liabilities	$600.0K	$400.0K
YoY Change	50.0%	33.33%
Total Long-Term Liabilities	$39.50M	$39.20M
YoY Change	0.77%	97.98%
TOTAL LIABILITIES
Total Short-Term Liabilities	$502.1M	$509.2M
Total Long-Term Liabilities	$39.50M	$39.20M
Total Liabilities	$541.6M	$548.5M
YoY Change	-1.26%	77.22%
SHAREHOLDERS EQUITY
Retained Earnings	$5.841M	-$969.8K
YoY Change	-702.27%	-84.12%
Common Stock	$249.4K	$236.8K
YoY Change	5.3%	0.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$114.0M	$108.8M
YoY Change
Total Liabilities & Shareholders Equity	$655.7M	$657.4M
YoY Change	-0.26%	43.05%

Cashflow Statement

Concept	2020 Q2	2019 Q2
OPERATING ACTIVITIES
Net Income	$1.879M	$1.394M
YoY Change	34.77%	-106.49%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$2.780M	-$170.0K
YoY Change	-1735.29%	-104.34%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$5.740M	-$14.00M
YoY Change	-141.0%	-101.16%
Cash From Investing Activities	$5.740M	-$14.00M
YoY Change	-141.0%	-101.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-10.49M	-1.790M
YoY Change	486.03%	-99.85%
NET CHANGE
Cash From Operating Activities	2.780M	-170.0K
Cash From Investing Activities	5.740M	-14.00M
Cash From Financing Activities	-10.49M	-1.790M
Net Change In Cash	-1.970M	-15.96M
YoY Change	-87.66%	-158.25%
FREE CASH FLOW
Cash From Operating Activities	$2.780M	-$170.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001547546
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2020-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-35845
	dei	Entity Registrant Name EntityRegistrantName	HUNT COMPANIES FINANCE TRUST, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-4966519
	dei	Entity Address Address Line1 EntityAddressAddressLine1	230 Park Avenue
	dei	Entity Address Address Line2 EntityAddressAddressLine2	19th Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10169
	dei	City Area Code CityAreaCode	212
	dei	Local Phone Number LocalPhoneNumber	521-6323
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
	dei	Trading Symbol TradingSymbol	HCFT
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2020Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	24943383	shares
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8856854	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10942115	USD
CY2020Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	7414097	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	5069715	USD
CY2020Q2	us-gaap	Notes Receivable Net NotesReceivableNet	609847568	USD
CY2019Q4	us-gaap	Notes Receivable Net NotesReceivableNet	635260420	USD
CY2020Q2	oaks	Mortgage Service Rights At Fair Value MortgageServiceRightsAtFairValue	1447282	USD
CY2019Q4	oaks	Mortgage Service Rights At Fair Value MortgageServiceRightsAtFairValue	2700207	USD
CY2020Q2	us-gaap	Deferred Offering Costs DeferredOfferingCosts	13333	USD
CY2019Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	40000	USD
CY2020Q2	us-gaap	Interest Receivable InterestReceivable	2172612	USD
CY2019Q4	us-gaap	Interest Receivable InterestReceivable	2342354	USD
CY2020Q2	oaks	Paydown Receivable PaydownReceivable	23781668	USD
CY2019Q4	oaks	Paydown Receivable PaydownReceivable	0	USD
CY2020Q2	us-gaap	Other Assets OtherAssets	2118494	USD
CY2019Q4	us-gaap	Other Assets OtherAssets	1547187	USD
CY2020Q2	us-gaap	Assets Assets	655651908	USD
CY2019Q4	us-gaap	Assets Assets	657901998	USD
CY2020Q2	oaks	Collateralized Loan Obligations CollateralizedLoanObligations	498311273	USD
CY2019Q4	oaks	Collateralized Loan Obligations CollateralizedLoanObligations	505930065	USD
CY2020Q2	us-gaap	Secured Long Term Debt SecuredLongTermDebt	39469649	USD
CY2019Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	39384041	USD
CY2020Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	428620	USD
CY2019Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	805126	USD
CY2020Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	1870754	USD
CY2019Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	1776912	USD
CY2020Q2	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	955500	USD
CY2019Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	991981	USD
CY2020Q2	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	554593	USD
CY2019Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	369161	USD
CY2020Q2	us-gaap	Liabilities Liabilities	541590389	USD
CY2019Q4	us-gaap	Liabilities Liabilities	549257286	USD
CY2020Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2020Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24943383	shares
CY2020Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24943383	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23692164	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23692164	shares
CY2020Q2	us-gaap	Common Stock Value CommonStockValue	249389	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	236877	USD
CY2020Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	233857707	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	228135116	USD
CY2020Q2	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	125985651	USD
CY2019Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	122236981	USD
CY2020Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	5840574	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2410200	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	113962019	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	108545212	USD
CY2020Q2	us-gaap	Minority Interest MinorityInterest	99500	USD
CY2019Q4	us-gaap	Minority Interest MinorityInterest	99500	USD
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	114061519	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	108644712	USD
CY2020Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	655651908	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	657901998	USD
CY2020Q2	us-gaap	Interest And Fee Income Loans Commercial Real Estate InterestAndFeeIncomeLoansCommercialRealEstate	8472153	USD
CY2019Q2	us-gaap	Interest And Fee Income Loans Commercial Real Estate InterestAndFeeIncomeLoansCommercialRealEstate	10289117	USD
	us-gaap	Interest And Fee Income Loans Commercial Real Estate InterestAndFeeIncomeLoansCommercialRealEstate	17637958	USD
	us-gaap	Interest And Fee Income Loans Commercial Real Estate InterestAndFeeIncomeLoansCommercialRealEstate	20193305	USD
CY2020Q2	us-gaap	Interest Income Securities Mortgage Backed InterestIncomeSecuritiesMortgageBacked	0	USD
CY2019Q2	us-gaap	Interest Income Securities Mortgage Backed InterestIncomeSecuritiesMortgageBacked	0	USD
	us-gaap	Interest Income Securities Mortgage Backed InterestIncomeSecuritiesMortgageBacked	0	USD
	us-gaap	Interest Income Securities Mortgage Backed InterestIncomeSecuritiesMortgageBacked	78361	USD
CY2020Q2	us-gaap	Interest Income And Fees Bankers Acceptances Certificates Of Deposit And Commercial Paper InterestIncomeAndFeesBankersAcceptancesCertificatesOfDepositAndCommercialPaper	7620	USD
CY2019Q2	us-gaap	Interest Income And Fees Bankers Acceptances Certificates Of Deposit And Commercial Paper InterestIncomeAndFeesBankersAcceptancesCertificatesOfDepositAndCommercialPaper	0	USD
	us-gaap	Interest Income And Fees Bankers Acceptances Certificates Of Deposit And Commercial Paper InterestIncomeAndFeesBankersAcceptancesCertificatesOfDepositAndCommercialPaper	35787	USD
	us-gaap	Interest Income And Fees Bankers Acceptances Certificates Of Deposit And Commercial Paper InterestIncomeAndFeesBankersAcceptancesCertificatesOfDepositAndCommercialPaper	0	USD
CY2020Q2	oaks	Interest Expense Collateralized Loan Obligations InterestExpenseCollateralizedLoanObligations	2915638	USD
CY2019Q2	oaks	Interest Expense Collateralized Loan Obligations InterestExpenseCollateralizedLoanObligations	5456288	USD
	oaks	Interest Expense Collateralized Loan Obligations InterestExpenseCollateralizedLoanObligations	7153527	USD
	oaks	Interest Expense Collateralized Loan Obligations InterestExpenseCollateralizedLoanObligations	10903177	USD
CY2020Q2	oaks	Interest Expense Secured Term Loan InterestExpenseSecuredTermLoan	780441	USD
CY2019Q2	oaks	Interest Expense Secured Term Loan InterestExpenseSecuredTermLoan	786114	USD
	oaks	Interest Expense Secured Term Loan InterestExpenseSecuredTermLoan	1560882	USD
	oaks	Interest Expense Secured Term Loan InterestExpenseSecuredTermLoan	1115227	USD
CY2020Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	4783694	USD
CY2019Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	4046715	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	8959336	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	8253262	USD
CY2020Q2	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	USD
CY2019Q2	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	USD
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	USD
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-709439	USD
CY2020Q2	oaks	Unrealized Gain Loss On Mortgage Service Rights UnrealizedGainLossOnMortgageServiceRights	-375176	USD
CY2019Q2	oaks	Unrealized Gain Loss On Mortgage Service Rights UnrealizedGainLossOnMortgageServiceRights	-459119	USD
	oaks	Unrealized Gain Loss On Mortgage Service Rights UnrealizedGainLossOnMortgageServiceRights	-1252925	USD
	oaks	Unrealized Gain Loss On Mortgage Service Rights UnrealizedGainLossOnMortgageServiceRights	-839117	USD
CY2020Q2	oaks	Unrealized Gain Loss On Multifamily Loans Held In Securitization Trusts UnrealizedGainLossOnMultifamilyLoansHeldInSecuritizationTrusts	0	USD
CY2019Q2	oaks	Unrealized Gain Loss On Multifamily Loans Held In Securitization Trusts UnrealizedGainLossOnMultifamilyLoansHeldInSecuritizationTrusts	0	USD
	oaks	Unrealized Gain Loss On Multifamily Loans Held In Securitization Trusts UnrealizedGainLossOnMultifamilyLoansHeldInSecuritizationTrusts	0	USD
	oaks	Unrealized Gain Loss On Multifamily Loans Held In Securitization Trusts UnrealizedGainLossOnMultifamilyLoansHeldInSecuritizationTrusts	694339	USD
CY2020Q2	us-gaap	Fees And Commissions Mortgage Banking And Servicing FeesAndCommissionsMortgageBankingAndServicing	204380	USD
CY2019Q2	us-gaap	Fees And Commissions Mortgage Banking And Servicing FeesAndCommissionsMortgageBankingAndServicing	185465	USD
	us-gaap	Fees And Commissions Mortgage Banking And Servicing FeesAndCommissionsMortgageBankingAndServicing	398527	USD
	us-gaap	Fees And Commissions Mortgage Banking And Servicing FeesAndCommissionsMortgageBankingAndServicing	433679	USD
CY2020Q2	us-gaap	Other Income OtherIncome	0	USD
CY2019Q2	us-gaap	Other Income OtherIncome	0	USD
	us-gaap	Other Income OtherIncome	2	USD
	us-gaap	Other Income OtherIncome	0	USD
CY2020Q2	oaks	Other Noninterest Income Loss OtherNoninterestIncomeLoss	-170796	USD
CY2019Q2	oaks	Other Noninterest Income Loss OtherNoninterestIncomeLoss	-273654	USD
	oaks	Other Noninterest Income Loss OtherNoninterestIncomeLoss	-854396	USD
	oaks	Other Noninterest Income Loss OtherNoninterestIncomeLoss	-420538	USD
CY2020Q2	us-gaap	Management Fee Expense ManagementFeeExpense	590211	USD
CY2019Q2	us-gaap	Management Fee Expense ManagementFeeExpense	566164	USD
	us-gaap	Management Fee Expense ManagementFeeExpense	1175032	USD
	us-gaap	Management Fee Expense ManagementFeeExpense	1119623	USD
CY2020Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	978842	USD
CY2019Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	895659	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1744734	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2362344	USD
CY2020Q2	oaks	Reimbursable Operating Expense ReimbursableOperatingExpense	346653	USD
CY2019Q2	oaks	Reimbursable Operating Expense ReimbursableOperatingExpense	517000	USD
	oaks	Reimbursable Operating Expense ReimbursableOperatingExpense	807774	USD
	oaks	Reimbursable Operating Expense ReimbursableOperatingExpense	1057037	USD
CY2020Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-833998	USD
CY2019Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-147259	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-1134924	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-185016	USD
CY2020Q2	us-gaap	Share Based Compensation ShareBasedCompensation	52762	USD
CY2019Q2	us-gaap	Share Based Compensation ShareBasedCompensation	50064	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	106894	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	100087	USD
CY2020Q2	us-gaap	Noninterest Expense NoninterestExpense	2802466	USD
CY2019Q2	us-gaap	Noninterest Expense NoninterestExpense	2176146	USD
	us-gaap	Noninterest Expense NoninterestExpense	4969358	USD
	us-gaap	Noninterest Expense NoninterestExpense	4824107	USD
CY2020Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	1810432	USD
CY2019Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	1596915	USD
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	3135582	USD
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	3008617	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-68271	USD
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	202745	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-294792	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	139680	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	1878703	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	1394170	USD
	us-gaap	Net Income Loss NetIncomeLoss	3430374	USD
	us-gaap	Net Income Loss NetIncomeLoss	2868937	USD
CY2020Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	3750	USD
CY2019Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	3792	USD
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	7500	USD
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	484264	USD
CY2020Q2	oaks	Deemed Preferred Stock Dividend On Related Redemptions DeemedPreferredStockDividendOnRelatedRedemptions	0	USD
CY2019Q2	oaks	Deemed Preferred Stock Dividend On Related Redemptions DeemedPreferredStockDividendOnRelatedRedemptions	0	USD
	oaks	Deemed Preferred Stock Dividend On Related Redemptions DeemedPreferredStockDividendOnRelatedRedemptions	0	USD
	oaks	Deemed Preferred Stock Dividend On Related Redemptions DeemedPreferredStockDividendOnRelatedRedemptions	3093028	USD
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1874953	USD
CY2019Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1390378	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3422874	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-708355	USD
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1874953	USD
CY2019Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1390378	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3422874	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-708355	USD
CY2020Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	24939575	shares
CY2019Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	23687664	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	24925529	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	23687664	shares
CY2020Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.08
CY2019Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.06
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.14
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.03
CY2020Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.08
CY2019Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.08
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.15
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.15
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	108644712	USD
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5747375	USD
CY2020Q1	oaks	Cost Of Issuing Of Common Stock Values CostOfIssuingOfCommonStockValues	13333	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	7882	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	1551671	USD
CY2020Q1	us-gaap	Dividends Common Stock DividendsCommonStock	1870416	USD
CY2020Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3750	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	114064141	USD
CY2020Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	14985	USD
CY2020Q2	oaks	Cost Of Issuing Of Common Stock Values CostOfIssuingOfCommonStockValues	13333	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	-8473	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	1878703	USD
CY2020Q2	us-gaap	Dividends Common Stock DividendsCommonStock	1870754	USD
CY2020Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3750	USD
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	114061519	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	150203338	USD
CY2019Q1	oaks	Cost Of Issuing Of Common Stock Values CostOfIssuingOfCommonStockValues	22383	USD
CY2019Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	40250000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	3773	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	1474767	USD
CY2019Q1	us-gaap	Dividends Common Stock DividendsCommonStock	1658136	USD
CY2019Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	480472	USD
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	109270887	USD
CY2019Q2	oaks	Cost Of Issuing Of Common Stock Values CostOfIssuingOfCommonStockValues	22382	USD
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	3814	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	1394170	USD
CY2019Q2	us-gaap	Dividends Common Stock DividendsCommonStock	1776575	USD
CY2019Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3792	USD
CY2019Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	108866122	USD
	us-gaap	Net Income Loss NetIncomeLoss	3430374	USD
	us-gaap	Net Income Loss NetIncomeLoss	2868937	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-570039	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-543372	USD
	oaks	Amortization Of Offering Costs AmortizationOfOfferingCosts	-26667	USD
	oaks	Amortization Of Offering Costs AmortizationOfOfferingCosts	-44765	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	512136	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	493750	USD
	oaks	Realized Gain Loss On Sale Of Investments RealizedGainLossOnSaleOfInvestments	0	USD
	oaks	Realized Gain Loss On Sale Of Investments RealizedGainLossOnSaleOfInvestments	-709439	USD
	oaks	Unrealized Gain Loss On Mortgage Service Rights UnrealizedGainLossOnMortgageServiceRights	-1252925	USD
	oaks	Unrealized Gain Loss On Mortgage Service Rights UnrealizedGainLossOnMortgageServiceRights	-839117	USD
	oaks	Unrealized Gain Loss On Multifamily Loans Held In Securitization Trust UnrealizedGainLossOnMultifamilyLoansHeldInSecuritizationTrust	0	USD
	oaks	Unrealized Gain Loss On Multifamily Loans Held In Securitization Trust UnrealizedGainLossOnMultifamilyLoansHeldInSecuritizationTrust	694339	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	14394	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	7587	USD
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-169742	USD
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	164388	USD
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-26667	USD
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-44766	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	571307	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	695988	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-376506	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-10768	USD
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-36481	USD
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	55900	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	185432	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-1618081	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5150748	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2334539	USD
	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	41990011	USD
	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	117536027	USD
	oaks	Repayments Of Principal To Repurchase Mortgage Loans Heldforsale RepaymentsOfPrincipalToRepurchaseMortgageLoansHeldforsale	0	USD
	oaks	Repayments Of Principal To Repurchase Mortgage Loans Heldforsale RepaymentsOfPrincipalToRepurchaseMortgageLoansHeldforsale	-4747049	USD
	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	67402863	USD
	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	72938556	USD
	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	23781668	USD
	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	-33042234	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1631184	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6808188	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5747375	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Payments For Repurchase Of Redeemable Preferred Stock PaymentsForRepurchaseOfRedeemablePreferredStock	0	USD
	us-gaap	Payments For Repurchase Of Redeemable Preferred Stock PaymentsForRepurchaseOfRedeemablePreferredStock	40250000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	3647328	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	3079396	USD
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	7500	USD
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	528614	USD
	oaks	Proceeds From Collateralized Loan Obligations ProceedsFromCollateralizedLoanObligations	0	USD
	oaks	Proceeds From Collateralized Loan Obligations ProceedsFromCollateralizedLoanObligations	0	USD
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	USD
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	40250000	USD
	oaks	Payment Of Collateralized Loan Obligations PaymentOfCollateralizedLoanObligations	8615358	USD
	oaks	Payment Of Collateralized Loan Obligations PaymentOfCollateralizedLoanObligations	0	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16011830	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6522811	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	59213812	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16270951	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1090372	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4698382	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	259121	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9172031	USD
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	50041781	USD
	us-gaap	Interest Paid Net InterestPaidNet	8008740	USD
	us-gaap	Interest Paid Net InterestPaidNet	10992050	USD
CY2020Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	1870754	USD
CY2019Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	1776575	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;">Use of Estimates</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">The financial statements have been prepared on the accrual basis of accounting in accordance with GAAP. The preparation of financial statements in conformity with GAAP requires the Company to make a number of significant estimates. On March 11, 2020, the World Health Organization ("WHO") declared COVID-19 a global pandemic, which continues to spread throughout the United States and around the world. The outbreak has adversely impacted, and continues to adversely impact economic and market conditions globally, nationally and locally. Actions taken around the world to help mitigate the spread of COVID-19 include imposition of quarantines, "stay-at-home" orders, restrictions on travel and forced closures for certain types of public places, businesses and schools. The prolonged duration of the COVID-19 pandemic and its impact on our borrowers and their tenants, cash flows and future results of operations could be significant and will largely depend on future developments, which are highly uncertain and cannot be predicted. We believe the estimates and </span></div>assumptions underlying our consolidated financial statements are reasonable and supportable based on the information available as of June 30, 2020, however uncertainty over the ultimate impact of COVID-19 on the global economy generally, and our business in particular, makes any estimates and assumptions inherently less certain than they would be absent the current and potential impacts of COVID-19. Actual results could differ from its estimates and the differences may be material.
CY2020Q2	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	0	USD
CY2020Q2	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	0	USD
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8856854	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10942115	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16270951	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16011830	USD
CY2020Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	0	USD
CY2020Q2	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	1017419	USD
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2020Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24943383	shares
CY2020Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24943383	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23692164	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23692164	shares
CY2015Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	10000000	USD
CY2019Q4	oaks	Income Tax Examination Accrued Tax Liability IncomeTaxExaminationAccruedTaxLiability	1960000	USD
CY2019Q4	oaks	Average Risk Rate AverageRiskRate	2.8
CY2020Q2	oaks	One Month Libor Rate OneMonthLIBORRate	0.0017	USD
CY2019Q4	oaks	One Month Libor Rate OneMonthLIBORRate	0.0170	USD
CY2020Q2	oaks	Weighted Average Libor Floor Rate WeightedAverageLIBORFloorRate	0.0161	USD
CY2019Q4	oaks	Weighted Average Libor Floor Rate WeightedAverageLIBORFloorRate	0.0156	USD
CY2020Q2	oaks	Average Risk Rate AverageRiskRate	3.0
CY2018Q2	oaks	Number Of Loan Participations NumberOfLoanParticipations	8	Loan_Participation
CY2019Q1	oaks	Collateralized Loan Obligation Unamortized Discount CollateralizedLoanObligationUnamortizedDiscount	39200000	USD
CY2020Q2	oaks	Collateralized Loan Obligation Deferred Financing Costs CollateralizedLoanObligationDeferredFinancingCosts	780351	USD
CY2019Q4	oaks	Collateralized Loan Obligation Deferred Financing Costs CollateralizedLoanObligationDeferredFinancingCosts	865959	USD
CY2020Q2	us-gaap	Secured Debt SecuredDebt	40250000	USD
CY2020Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	40250000	USD
CY2019Q4	us-gaap	Secured Debt SecuredDebt	40250000	USD
CY2019Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	40250000	USD
CY2020Q2	us-gaap	Secured Debt SecuredDebt	40250000	USD
CY2020Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	40250000	USD
CY2019Q4	us-gaap	Secured Debt SecuredDebt	40250000	USD
CY2019Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	40250000	USD
CY2020Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	1447282	USD
CY2019Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	2700207	USD
CY2019	oaks	Management Fee Percentage ManagementFeePercentage	0.015
CY2019	oaks	Quarterly Management Fee Percentage QuarterlyManagementFeePercentage	0.00375
CY2020Q2	us-gaap	Management Fee Expense ManagementFeeExpense	590211	USD
CY2019Q2	us-gaap	Management Fee Expense ManagementFeeExpense	566164	USD
CY2020Q2	us-gaap	Management Fee Payable ManagementFeePayable	588000	USD
CY2019Q2	us-gaap	Management Fee Payable ManagementFeePayable	567000	USD
	us-gaap	Management Fee Expense ManagementFeeExpense	1175032	USD
	us-gaap	Management Fee Expense ManagementFeeExpense	1119623	USD
CY2020Q2	us-gaap	Management Fee Payable ManagementFeePayable	588000	USD
CY2019Q2	us-gaap	Management Fee Payable ManagementFeePayable	567000	USD
CY2020Q2	oaks	Reimbursable Operating Expense ReimbursableOperatingExpense	346653	USD
CY2019Q2	oaks	Reimbursable Operating Expense ReimbursableOperatingExpense	517000	USD
CY2020Q2	oaks	Reimbursable Costs Payable ReimbursableCostsPayable	367500	USD
CY2019Q2	oaks	Reimbursable Costs Payable ReimbursableCostsPayable	663900	USD
CY2020Q2	oaks	Exit Fee Waived Percentage Reduced ExitFeeWaivedPercentageReduced	0.50
CY2020Q2	oaks	Reimbursable Operating Expense Waived ReimbursableOperatingExpenseWaived	147097	USD
CY2019Q2	oaks	Reimbursable Operating Expense Waived ReimbursableOperatingExpenseWaived	0	USD
	oaks	Reimbursable Operating Expense ReimbursableOperatingExpense	807774	USD
	oaks	Reimbursable Operating Expense ReimbursableOperatingExpense	1057037	USD
CY2020Q2	oaks	Reimbursable Costs Payable ReimbursableCostsPayable	367500	USD
CY2019Q2	oaks	Reimbursable Costs Payable ReimbursableCostsPayable	663900	USD
	oaks	Exit Fee Waived Percentage Reduced ExitFeeWaivedPercentageReduced	0.50
	oaks	Reimbursable Operating Expense Waived ReimbursableOperatingExpenseWaived	73549	USD
	oaks	Reimbursable Operating Expense Waived ReimbursableOperatingExpenseWaived	0	USD
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2020Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24943383	shares
CY2020Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24943383	shares
CY2020Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24943383	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23692164	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23692164	shares
CY2015Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	10000000	USD
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1610000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1610000	shares
	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.0875
CY2019Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	25.00
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	1878703	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	1394170	USD
CY2020Q2	us-gaap	Dividends Common Stock DividendsCommonStock	1870754	USD
CY2019Q2	us-gaap	Dividends Common Stock DividendsCommonStock	1776575	USD
CY2020Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3750	USD
CY2019Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3792	USD
CY2020Q2	us-gaap	Dividends Dividends	1874504	USD
CY2019Q2	us-gaap	Dividends Dividends	1780367	USD
CY2020Q2	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Basic UndistributedEarningsLossAvailableToCommonShareholdersBasic	4199	USD
CY2019Q2	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Basic UndistributedEarningsLossAvailableToCommonShareholdersBasic	-386197	USD
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24935372	shares
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23683164	shares
CY2020Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4203	shares
CY2019Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4500	shares
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24939575	shares
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23687664	shares
	us-gaap	Net Income Loss NetIncomeLoss	3430374	USD
	us-gaap	Net Income Loss NetIncomeLoss	2868937	USD
	us-gaap	Dividends Common Stock DividendsCommonStock	3741170	USD
	us-gaap	Dividends Common Stock DividendsCommonStock	3434711	USD
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	7500	USD
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	484264	USD
	oaks	Deemed Preferred Stock Dividend On Related Redemptions DeemedPreferredStockDividendOnRelatedRedemptions	0	USD
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24925529	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24925529	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23687664	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23687664	shares
	oaks	Deemed Preferred Stock Dividend On Related Redemptions DeemedPreferredStockDividendOnRelatedRedemptions	3093028	USD
	us-gaap	Dividends Dividends	3748670	USD
	us-gaap	Dividends Dividends	7012003	USD
	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Basic UndistributedEarningsLossAvailableToCommonShareholdersBasic	-318296	USD
	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Basic UndistributedEarningsLossAvailableToCommonShareholdersBasic	-4143066	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24921177	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24921177	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23683164	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23683164	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4352	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4352	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4500	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4500	shares
CY2018Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	1960000	USD

Files In Submission

Name	View Source	Status
0001628280-20-012181-index-headers.html	Edgar Link	pending
0001628280-20-012181-index.html	Edgar Link	pending
0001628280-20-012181.txt	Edgar Link	pending
0001628280-20-012181-xbrl.zip	Edgar Link	pending
a20200630exhibit101.htm	Edgar Link	pending
a20200630exhibit102.htm	Edgar Link	pending
a20200630exhibit103.htm	Edgar Link	pending
a20200630exhibit104.htm	Edgar Link	pending
a20200630exhibit31-1.htm	Edgar Link	pending
a20200630exhibit31-2.htm	Edgar Link	pending
a20200630exhibit32-1.htm	Edgar Link	pending
a20200630exhibit32-2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
oaks-20200630.htm	Edgar Link	pending
oaks-20200630.xsd	Edgar Link	pending
oaks-20200630_cal.xml	Edgar Link	unprocessable
oaks-20200630_def.xml	Edgar Link	unprocessable
oaks-20200630_htm.xml	Edgar Link	completed
oaks-20200630_lab.xml	Edgar Link	unprocessable
oaks-20200630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LFT
Lument Finance Trust, Inc. Stock $lft

2020 Q2 Form 10-Q Financial Statement

#000162828020012181 Filed on August 07, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFT Lument Finance Trust, Inc. Stock $lft

2020 Q2 Form 10-Q Financial Statement

#000162828020012181 Filed on August 07, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFT
Lument Finance Trust, Inc. Stock $lft